glp-1 agonist gila monster venom… and weight loss? 🦎 It sounds wild, but it's true. medications were inspired by a hormone first discovered in the saliva of a Gila monster. On this week's Lessons from the Gila Monster:

Identifying the metabolic or physiological abnormalities associated with ASD is important, as treatments for such abnormalities may be possible

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

Oral glutathione is considered a safer alternative to IV glutathione or glutathione injections, and is allowed without prescription

EU shipping

Storage: Keep in a cool, dry place at 1530C (5986F)